BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23085249)

  • 1. The dynamic biliary epithelia: molecules, pathways, and disease.
    O'Hara SP; Tabibian JH; Splinter PL; LaRusso NF
    J Hepatol; 2013 Mar; 58(3):575-82. PubMed ID: 23085249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cholangiopathies.
    Lazaridis KN; LaRusso NF
    Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in Cholangiopathies.
    O'Hara SP; Gradilone SA; Masyuk TV; Tabibian JH; LaRusso NF
    Curr Pathobiol Rep; 2014 Sep; 2(3):133-142. PubMed ID: 25097819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocyte pathobiology.
    Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
    Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport systems in cholangiocytes: their role in bile formation and cholestasis.
    Strazzabosco M
    Yale J Biol Med; 1997; 70(4):427-34. PubMed ID: 9626763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
    Pinto C; Giordano DM; Maroni L; Marzioni M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging concepts in biliary repair and fibrosis.
    Fabris L; Spirli C; Cadamuro M; Fiorotto R; Strazzabosco M
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G102-G116. PubMed ID: 28526690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in cholangiocyte immunobiology.
    Syal G; Fausther M; Dranoff JA
    Am J Physiol Gastrointest Liver Physiol; 2012 Nov; 303(10):G1077-86. PubMed ID: 22961800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of the intrahepatic biliary epithelium.
    Glaser S; Francis H; Demorrow S; Lesage G; Fava G; Marzioni M; Venter J; Alpini G
    World J Gastroenterol; 2006 Jun; 12(22):3523-36. PubMed ID: 16773709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiologic and pathologic experimental models for studying cholangiocytes].
    Lee SO
    Korean J Hepatol; 2008 Jun; 14(2):139-49. PubMed ID: 18617761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and benign biliary tract diseases.
    Gradilone SA; O'Hara SP; Masyuk TV; Pisarello MJ; LaRusso NF
    Semin Liver Dis; 2015 Feb; 35(1):26-35. PubMed ID: 25632932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathobiology of biliary epithelia.
    Alpini G; McGill JM; Larusso NF
    Hepatology; 2002 May; 35(5):1256-68. PubMed ID: 11981776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.
    Giordano DM; Pinto C; Maroni L; Benedetti A; Marzioni M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.
    Fabris L; Fiorotto R; Spirli C; Cadamuro M; Mariotti V; Perugorria MJ; Banales JM; Strazzabosco M
    Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):497-511. PubMed ID: 31165788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells.
    Dianat N; Dubois-Pot-Schneider H; Steichen C; Desterke C; Leclerc P; Raveux A; Combettes L; Weber A; Corlu A; Dubart-Kupperschmitt A
    Hepatology; 2014 Aug; 60(2):700-14. PubMed ID: 24715669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.
    Nejak-Bowen K
    Gene Expr; 2020 Jun; 20(1):19-23. PubMed ID: 31439080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of functional ciliated cholangiocytes from human pluripotent stem cells.
    Ogawa M; Jiang JX; Xia S; Yang D; Ding A; Laselva O; Hernandez M; Cui C; Higuchi Y; Suemizu H; Dorrell C; Grompe M; Bear CE; Ogawa S
    Nat Commun; 2021 Nov; 12(1):6504. PubMed ID: 34764255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.
    Fiorotto R; Villani A; Kourtidis A; Scirpo R; Amenduni M; Geibel PJ; Cadamuro M; Spirli C; Anastasiadis PZ; Strazzabosco M
    Hepatology; 2016 Dec; 64(6):2118-2134. PubMed ID: 27629435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammatory and neoplastic cholangiopathies.].
    Alvaro D; Bragazzi MC; Ridola L
    Recenti Prog Med; 2018 Dec; 109(12):595-599. PubMed ID: 30667389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repopulating the biliary tree from the peribiliary glands.
    de Jong IEM; van Leeuwen OB; Lisman T; Gouw ASH; Porte RJ
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1524-1531. PubMed ID: 28778591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.